Mechanistic Rationale of Seladelpar's Clinical Efficacy through the Selective PPAR-δ Activation in Primary Biliary

Alessio Gerussi1, Matteo Fornai2

  • 1Centre for Autoimmune Liver Diseases, Division of Gastroenterology, Fondazione IRCCS San Gerardo dei Tintori, ERN-RARE LIVER Center, Monza, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Pharmacological Research
|February 19, 2026
PubMed
Abstract